Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H12BrNO |
| Molecular Weight | 194.07 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(Br)(CC)C(N)=O
InChI
InChIKey=ACEYAMOAGUDVAQ-UHFFFAOYSA-N
InChI=1S/C6H12BrNO/c1-3-6(7,4-2)5(8)9/h3-4H2,1-2H3,(H2,8,9)
| Molecular Formula | C6H12BrNO |
| Molecular Weight | 194.07 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Carbromide is containing bromide mild hypnotic synthesized in 1908 by German chemists. Carbromide is one of a number of hypnotics containing bromide, which releases the bromide ion on hydrolysis in the bodyChronic administration can cause accumulation of bromide ions which have the same distribution as chloride ions but are not actively transported out of cells and are excreted in the urine with a half-life of 10-12 days. Bromism may result from chronic Carbromide ingestion and with a plasma bromine concentration of 10-15 mM, the signs are acne, cerebral retardation, cerebellar dysfunction, hyperreflexia, extensor plantar responses, and gastro¬intestinal symptoms. The risk of bromism developing makes Carbromide a more dangerous drug than most other hypnotics.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:12:39 GMT 2025
by
admin
on
Mon Mar 31 21:12:39 GMT 2025
|
| Record UNII |
6BTQ2OHW47
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80199108
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | |||
|
208-132-2
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | |||
|
10535
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | |||
|
511-70-6
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | |||
|
6BTQ2OHW47
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | |||
|
4607
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | |||
|
m692
Created by
admin on Mon Mar 31 21:12:39 GMT 2025 , Edited by admin on Mon Mar 31 21:12:39 GMT 2025
|
PRIMARY | Merck Index |